Carolinas Wealth Consulting’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11
| Closed | -$1.18K | – | 613 |
|
|
2025
Q1 | $1.18K | Buy |
11
+1
| +10% | +$107 | ﹤0.01% | 893 |
|
|
2024
Q4 | $1.29K | Buy |
10
+4
| +67% | +$517 | ﹤0.01% | 903 |
|
|
2024
Q3 | $613 | Hold |
6
| – | – | ﹤0.01% | 987 |
|
|
2024
Q2 | $732 | Buy |
6
+1
| +20% | +$122 | ﹤0.01% | 950 |
|
|
2024
Q1 | $684 | Sell |
5
-7
| -58% | -$958 | ﹤0.01% | 952 |
|
|
2023
Q4 | $1.53K | Hold |
12
| – | – | ﹤0.01% | 772 |
|
|
2023
Q3 | $1.29K | Buy |
12
+7
| +140% | +$751 | ﹤0.01% | 788 |
|
|
2023
Q2 | $440 | Buy |
5
+1
| +25% | +$88 | ﹤0.01% | 1014 |
|
|
2023
Q1 | $405 | Hold |
4
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q4 | $478 | Buy |
+4
| New | +$478 | ﹤0.01% | 998 |
|